【Dayeh Biomedical】Report on the Completion of Share Buyback Period
NQ Score
44/100
N1 Content Completeness
9
AI Summary (NQ-processed)
Dayeh Biomedical executed a share buyback from March 31 to May 25, 115. Out of the planned 7.5 million shares, 4.46 million were repurchased at an average price of 18.48 TWD, totaling 82.41 million TWD. The shortfall was due to a phased buyback strategy to maintain market stability.
AI Analysis
Frequently Asked Questions
- Q: What is the result of Dayeh Biomedical's buyback?
- A: They repurchased 4.46 million shares for approximately 82.41 million TWD.